[Edaily Reporter Park Jung-Soo ] WONTECH(336570)announced on the 30th that it held the global brand event “Wave Bangkok 2026” at the Conrad Hotel in Bangkok, Thailand. This event was organized to share the company’s achievements in Thailand—which has established itself as a key Asian hub since the Thai subsidiary was founded in 2023—and to present a vision for expanding the brand across the broader Asian market based on these accomplishments. The event was attended by medical professionals and partners from Thailand and other Asian countries. WONTECH unveiled its new corporate identity (CI), introduced its global growth strategy and brand direction, and expressed its determination to leap forward as a global medical solutions company. The academic program consisted of two panel sessions. In the first session, medical professionals from various Asian countries participated to share the latest treatment protocols for “Oligio X” under the theme of monopolar RF solutions suitable for Asian skin. In the second session, medical professionals from South Korea and Thailand jointly presented laser treatment strategies and clinical experiences optimized for the characteristics of Asian skin. A WONTECH representative stated, “This Wave Bangkok event was a meaningful occasion where we directly shared WONTECH’s global brand vision with medical professionals,” adding, “Moving forward, we will continue to connect country-specific clinical experiences with innovative technologies through WAVE and build a brand ecosystem that grows alongside global medical professionals, with Thailand serving as our Asian hub.” Meanwhile, WAVE (WONTECH Advanced Visionary Exchange) is a global brand event where WONTECH shares its technological capabilities and clinical experience with medical professionals and partners. Beginning in South Korea last March, the event has been held in six countries—including the United States, Japan, Taiwan, China, and Thailand—and is establishing itself as a global platform for medical professional exchange.
Construction on the Yongin National Industrial Complex for Advanced System Semiconductors, a project involving an investment of approximately 360 trillion won by SamsungElectronics, is set to begin th…
The KRX Health Care Index rose 4.53% from the previous session on Oct. 1, signaling a rare tailwind for South Korea’s pharmaceutical and biotech sector. Among the gainers, GIInnovation and G2GBio drew…
(Graphic: ChatGPT)
“While existing ex vivo chimeric antigen receptor T-cell (CAR-T) therapies are personalized treatments that require cell collection from each patient for manufacturing, the in v…